Caulerpa racemosa
Caulerpa racemosa has been studied in 1 paper since 2022: 1 trial in people. The newest paper, Jul 14, 2022: “Metabolomic Assay, Computational Screening, and Pharmacological Evaluation of Caulerpa racemosa as an Anti-obesity With Anti-aging by Altering Lipid Profile and Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α Levels”.
1 paper studies it6 findingsUpdated
See all 1 papers on caulerpa racemosa
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“After 4 weeks of intervention, there was a significant decrease (p < 0.05) in BG, TC, LDL, TG, waist circumference, WHR (p = 0.000), and body weight (p = 0.026).”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: University of Brawijaya
- Human trial1
Studies in people
1 study gave caulerpa racemosa to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases body weight up: Increases high-density lipoprotein cholesterol | Trial4 weeks | 70 peopleOnly men29.98 ± 3.26 yearsObese men without other diagnosed diseases | Frontiers in nutrition, Jul 14, 2022 |
What did studies of caulerpa racemosa find?
3Studies of caulerpa racemosa measured 3 outcomes: PPARGC1A, high-density lipoprotein cholesterol and body weight.
PPARGC1A
upin humans1
1 study
PPARGC1A
upin humans1
Caulerpa racemosa increases PPARGC1A in humans (compared with placebo).
“There was also a significant increase (p = 0.000) in PGC-1α and HDL, respectively, in the sea grape extract group when compared with the placebo group.”
Human trialcompared with placebo4 weeksn = 69
Frontiers in nutrition
Caulerpa racemosa increases PPARGC1A in humans (compared with Group A) (p = 0.000).
“PGC-1α and high-density lipoprotein (HDL) increased significantly (p = 0.000), in Group B when compared with Group A.”
Human trialcompared with Group A4-week
Frontiers in nutrition
High-density lipoprotein cholesterol
upin humans1
1 study
High-density lipoprotein cholesterol
upin humans1
Caulerpa racemosa increases high-density lipoprotein cholesterol in humans (compared with placebo).
“There was also a significant increase (p = 0.000) in PGC-1α and HDL, respectively, in the sea grape extract group when compared with the placebo group.”
Human trialcompared with placebo4 weeksn = 69
Frontiers in nutrition
Caulerpa racemosa increases high-density lipoprotein cholesterol in humans (compared with Group A) (p = 0.000).
“PGC-1α and high-density lipoprotein (HDL) increased significantly (p = 0.000), in Group B when compared with Group A.”
Human trialcompared with Group A4-week
Frontiers in nutrition
Body weight
downin humans1
1 study
Body weight
downin humans1
Caulerpa racemosa decreases body weight in humans (compared with placebo).
“After 4 weeks of intervention, there was a significant decrease (p < 0.05) in BG, TC, LDL, TG, waist circumference, WHR (p = 0.000), and body weight (p = 0.026).”
Human trialcompared with placebo4 weeksn = 69
Frontiers in nutrition
Caulerpa racemosa decreases body weight in humans (compared with Group A) (p < 0.05).
“There was a significant decrease in blood glucose, total cholesterol, low-density lipoprotein (LDL), triglycerides (TG), waist circumference, waist-hip ratio, and body weight (p < 0.05)”
Human trialcompared with Group A4-week
Frontiers in nutrition